Processing your payment...
Please do not close your browser.

Attention Deficit Hyperactivity Disorder (ADHD) Market - Global Growth, Trends and Forecast (2022 - 2027) By Types, By Application, By Regions and By Key market Takeda, Johnson & Johnson, Novartis

25 Mar, 2022 | 131 Pages
Shares
facebook sharing button
linkedin sharing button
twitter sharing button
sharethis sharing button

Registering a CAGR of 6.8% over the forecast period of 2022-2027, the global Attention Deficit Hyperactivity Disorder (ADHD) market is anticipated to reach the market value of US$ 24.8 billion in the year 2027 from US$ 22.6 billion in the year 2021.



Attention Deficit Hyperactivity Disorder (ADHD) Market Overview



Attention-deficit hyperactivity disorder is known as a brain disorder in which the patient is hyperactive, impulsive and has absenteeism of attention. The reason for this disorder is not yet identified but it is anticipated that a several factors such as genes, pre-natal brain injuries, exposure of toxins so forth are responsible for ADHD. Features such as the upsurge on emphasis and advancements in medical field to advance advanced products for ADHD and the growth in responsiveness about mental illness amongst people are the factors expected to boost the growth of the attention-deficit hyperactivity disorder (ADHD) market in the forecast period.



The report aspects discussed the profile of the top manufacturers of the global Attention Deficit Hyperactivity Disorder (ADHD) market. These aspects include financial status of major companies, trending advancements and entire market scenario. Growth of the report have examined Attention Deficit Hyperactivity Disorder (ADHD) Market production, demand and growth potential, geographic analysis, as well as current market developments in various regions and countries.





What are the major Applications, Types and Regions for Attention Deficit Hyperactivity Disorder (ADHD) Market?



By Type, it is segmented into




  • Stimulant

  • Non-stimulant



By Applications it is segmented into




  • Hospital Pharmacy

  • Retail Pharmacy



Attention Deficit Hyperactivity Disorder (ADHD) Market Segments Analysis




  • The stimulant drugs segment accounted for the largest share in the market in 2018 and is anticipated to maintain its dominance during the forecast period. This can be attributed to effectiveness of drugs in treating of ADHD symptoms and commercialization of new drugs.

  • Retail pharmacy accounted for the largest share in 2018 due to increasing number of prescriptions. This can be attributed to rise in patient care initiatives by retail pharmacies



Attention Deficit Hyperactivity Disorder (ADHD) Market Regional Analysis



North America dominates the attention-deficit hyperactivity disorder (ADHD) market since of the large volume of drug prescriptions every year and the growing of the product launches. Furthermore, the growth in the collaboration amongst the companies to improve the market penetration and for the product expansion which in turn will further boost the growth of the attention-deficit hyperactivity disorder (ADHD) market in the region during the forecast period. The European ADHD market is second only to developing technology and digital medications. The industry's expansion is due to an affluent medical device market and rising healthcare expenditure. The ADHD treatments market in Asia Pacific is also growing. The unmet demands and large patient population, as well as the availability of lower-cost ADHD medications, have all contributed to the market's rise.




  • North America


    • US

    • Canada



  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe



  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific



  • Rest of the World

    • Middle East & Africa

    • Latin America





The Attention Deficit Hyperactivity Disorder (ADHD) Market describes the factors driving the global growth opportunities in upcoming years and highlights market channels. In addition, the report analyzes market size and share, trends, by geographic region, end-use type and segment. It focuses extensively on revealing a detailed regional analysis. The Global Attention Deficit Hyperactivity Disorder (ADHD) Market report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.



What is our Attention Deficit Hyperactivity Disorder (ADHD) Market report scope?























































Report Attributes



Report Details



Forecast Period 2022 to 2027 CAGR



CAGR of 6.8% over the forecast period (2022-2027)



By Type




  • Stimulant

  • Non-stimulant



By Application




  • Hospital Pharmacy

  • Retail Pharmacy



By Companies



Takeda, Johnson & Johnson, Novartis, Eli Lilly, Tris Pharma, Neos Therapeutics, Mallinckrodt, Amneal Pharmaceuticals, Noven Pharmaceuticals, Purdue Parma, CTFH



Regions Covered




  • North America

  • Europe

  • Asia-Pacific

  • Rest of the World



Countries Covered




  • US

  • Canada

  • Germany

  • France

  • UK

  • Italy

  • Spain

  • Rest of Europe

  • China

  • Japan

  • India

  • Australia

  • South Korea

  • Rest of Asia-Pacific

  • Middle East & Africa

  • Latin America



Base Year



2022



Historical Year



2017 to 2021



Forecast Year



2022 to 2027



Number of Pages



131



Customization Available



Yes, the report can be customized as per your needs




 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



 



Key Takeaways from this Attention Deficit Hyperactivity Disorder (ADHD) Report




  • Evaluate Attention Deficit Hyperactivity Disorder (ADHD) market potential through analyzing growth rates (CAGR %), Volume (Units) and Value ($M) data given at country level - for product types, end use applications and by different industry verticals.

  • Understand the different dynamics influencing the market - growth driving factors, specific challenges and hidden opportunities.

  • Get in-depth insights on your competitor performance – revenue, shares, business strategies, financial benchmarking, product benchmarking, SWOT analysis and more.

  • Analyze the sales and distribution channels across geographies to enhance top-line revenues.

  • Understand the demanding supply chain with a deep dive on the value augmentation at each, in order to optimize value and bring efficiencies in your processes.

  • Get a quick outlook on the Attention Deficit Hyperactivity Disorder (ADHD) market entropy - M&A's, deals, partnerships, product launches of all key players for the past 4 years.

  • Evaluate the import-export statistics, supply-demand and competitive landscape for more than top 20 countries globally for the market.



Frequently Asked Questions



What is the growth rate of Attention Deficit Hyperactivity Disorder (ADHD)Market?



The Attention Deficit Hyperactivity Disorder (ADHD)Market is growing at a CAGR of 6.8% over the next 5 years.



Who are the key players in Attention Deficit Hyperactivity Disorder (ADHD)Market?



Takeda, Johnson & Johnson, Novartis, Eli Lilly, Tris Pharma, Neos Therapeutics, Mallinckrodt, Amneal Pharmaceuticals, Noven Pharmaceuticals, Purdue Parma, CTFH



What are the significant types of Attention Deficit Hyperactivity Disorder (ADHD)Market?



Stimulant, Non-stimulant



What are the major end-use applications of Attention Deficit Hyperactivity Disorder (ADHD)Market?



Hospital Pharmacy, Retail Pharmacy



On the basis of application, Which segment is likely to hold the major share in the Attention Deficit Hyperactivity Disorder (ADHD)Market?



Retail Pharmacy segment to hold the largest share in Attention Deficit Hyperactivity Disorder (ADHD)market



All our reports are custom made to your company needs to a certain extent, we do provide 5 free consulting hours along with purchase of each report, and this will allow you to request any additional data to customize the report as your needs.


  1. INTRODUCTION

    1. MARKET DEFINITION

    2. MARKET DYNAMICS

    3. MARKET SEGMENTATION

    4. REPORT TIMELINES

    5. KEY STAKEHOLDERS



  2. RESEARCH METHODOLOGY

    1. DATA MINING

      1. SECONDARY RESEARCH

      2. PRIMARY RESEARCH

      3. SUBJECT MATTER EXPERT ADVICE



    2. QUALITY CHECK

    3. FINAL REVIEW

      1. DATA TRIANGULATION

      2. BOTTOM-UP APPROACH

      3. TOP-DOWN APPROACH



    4. RESEARCH FLOW



  3. EXECUTIVE SUMMARY

    1. INTRODUCTION

    2. GLOBAL ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) BY TYPES

    3. GLOBAL ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) BY APPLICATION



  4. MARKET DYNAMICS

    1. DRIVERS

    2. INCREASING DEMAND FOR ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) RESTRAINTS

      1. STRINGENT ENVIRONMENTAL REGULATIONS

      2. HIGH COST OF MATERIALS



    3. OPPORTUNITIES

      1. ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)GROWTH



    4. APPLICATION OF ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)

    5. IMPACT OF COVID 19



  5. GLOBAL ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD), BY TYPES

    1. Introduction

    2. Stimulant

    3. Non-stimulant



  6. GLOBAL ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD), BY APPLICATION

    1. Introduction

    2. Hospital Pharmacy

    3. Retail Pharmacy



  7. GLOBAL ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD), BY REGION

    1. NORTH AMERICA

      1. US

      2. CANADA

      3. MEXICO



    2. EUROPE

      1. GERMAN

      2. FRANCE

      3. UK

      4. ITALY

      5. RUSSIA

      6. REST OF EUROPE



    3. APAC

      1. CHINA

      2. SOUTH KOREA

      3. JAPAN

      4. INDIA

      5. AUSTRALIA

      6. ASEAN

      7. REST OF APAC



    4. MIDDLE EAST & AFRICA

      1. SAUDI ARABIA

      2. UAE

      3. SOUTH AFRICA

      4. TURKEY

      5. REST OF MEA



    5. SOUTH AMERICA

      1. BRAZIL

      2. REST OF MEA

      3. ARGENTINA

      4. REST OF SOUTH AMERICA





  8. COMPETITIVE LANDSCAPE

    1. MERGERS, ACQUISITIONS, JOINT VENTURES, COLLABORATIONS,

    2. AND AGREEMENTS

      1. KEY DEVELOPMENT



    3. MARKET SHARE (%) **/RANKING ANALYSIS

    4. STRATEGIES ADOPTED BY LEADING PLAYERS



  9. COMPANY PROFILES

    1. BUSINESS OVERVIEW

    2. COMPANY SNAPSHOT

    3. PRODUCT BENCHMARKING

    4. STRATEGIC INITIATIVES

      1.     Takeda

      2.     Johnson & Johnson

      3.     Novartis

      4.     Eli Lilly

      5.     Tris Pharma

      6.     Neos Therapeutics

      7.     Mallinckrodt

      8.     Amneal Pharmaceuticals

      9.     Noven Pharmaceuticals

      10.     Purdue Parma

      11.     CTFH





SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.

PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.

MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.

EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.

REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.

Please Choose License Type

  • Single User License
    $2500
  • Site License
    $3000
  • Global License
    $5000

How can we help you?

Reach us with your research requirements and we shall provide the optimum solution to suit your needs.

Curioust about Multiple Reports?

Discounts available for multiple report purchases.

Contact Us

Our Clients

  • Merck
  • IBM
  • Dow
  • Henkel
  • AirBus
  • Cummins
  • Intel
  • Sony
  • 3M
  • 3M
  • 9